Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity

Journal of Neuroimmunology

Volumn 192, Issue 1-2, 2007, Pages 68-78

  Guan, Yangtai ^a   Yu, Shuo ^a   Zhao, Zhao ^a   Ciric, Bogoljub ^a   Zhang, Guang Xian ^a   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

APC; Experimental autoimmune encephalomyelitis; Suppression

Indexed keywords

AUTOANTIGEN; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLYCOPROTEINS; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; TIME FACTORS;

EID: 36749025082     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.021     Document Type: Article

References (44)

1. Bartocci A., Pollard J.W., and Stanley E.R. Regulation of colony-stimulating factor 1 during pregnancy. J. Exp. Med. 164 (1986) 956-961
2. Benson J.M., Campbell K.A., Guan Z., Gienapp I.E., Stuckman S.S., Forsthuber T., and Whitacre C.C. T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen. J. Clin. Invest. 106 (2000) 1031-1038
3. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197 (2003) 1073-1081
4. Brown J.A., Dorfman D.M., Ma F.R., Sullivan E.L., Munoz O., Wood C.R., Greenfield E.A., and Freeman G.J. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170 (2003) 1257-1266
5. Calida D.M., Constantinescu C., Purev E., Zhang G.X., Ventura E.S., Lavi E., and Rostami A. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice. J. Immunol. 166 (2001) 723-726
6. Chen Y., Langrish C.L., McKenzie B., Joyce-Shaikh B., Stumhofer J.S., McClanahan T., Blumenschein W., Churakovsa T., Low J., Presta L., Hunter C.A., Kastelein R.A., and Cua D.J. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116 (2006) 1317-1326
7. de Jong E.C., Smits H.H., and Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26 (2005) 289-307
8. Dittel B.N., Visintin I., Merchant R.M., and Janeway Jr. C.A. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol. 163 (1999) 32-39
9. Endharti A.T., Rifa'I M., Shi Z., Fukuoka Y., Nakahara Y., Kawamoto Y., Takeda K., Isobe K., and Suzuki H. Cutting edge: CD8+CD1229+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J. Immunol. 175 (2005) 7093-7097
10. Faunce D.E., Terajewicz A., and Stein-Streilein J. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 172 (2004) 1991-1995
11. Fitzgerald D.C., Ciric B., Touil T., Harle H., Grammatikopolou J., Das-Sarma J., Gran B., Zhang G.X., and Rostami A.M. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 179 (2007) 3268-3275
12. Hara Y., Caspi R.R., Wiggert B., Dorf M., and Streilein J.W. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J. Immunol. 1992. 149 (1992) 1531-1538
13. Hara Y., Okamoto S., Rouse B., and Streilein J.W. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. J. Immunol. 151 (1993) 5162-5171
14. Huang Y.M., Yang J.S., Xu L.Y., Link H., and Xiao B.G. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin. Exp. Immunol. 122 (2000) 437-444
15. Ikeno K., Koike K., Fukuromoto T., Shimizu T., Nagatomo M., and Komiyama A. Increased macrophage-colony stimulating factor levels in neonates with perinatal complications. Early Hum. Dev. 46 (1996) 229-237
16. Kapsenberg M.L., and Kalinski P. The concept of type 1 and type 2 antigen-presenting cells. Immunol. Lett. 69 (1999) 5-6
17. Keir M.E., Francisco L.M., and Sharpe A.H. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19 (2007) 309-314
18. Kleinschek M.A., Owyang A.M., Joyce-Shaikh B., Langrish C.L., Chen Y., Gorman D.M., Blumenschei W.M., McClanahan T., Brombacher F., Hurst S.D., Kastelein R.A., and Cua D.J. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204 (2007) 161-170
19. Kojima K., Naomoto Y., Hizuta A., Tanaka N., and Orita K. Cytokine production suppressive effect by macrophage colony-stimulating factor (M-CSF). Res. Commun. Mol. Pathol. Pharmacol. 91 (1996) 161-172
20. Kosiewicz M., Okamoto M.S., Miki S., Ksander B., Shimizu B.R., and Streilein J.W. Imposing deviant immunity on the presensitized state. J. Immunol. 153 (1994) 2962-2973
21. Larsen C.P., Knechtle S.J., Adams A., Pearson T., and Kirk A.D. A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression. Am. J. Transplant. 6 (2006) 876-883
22. Lee H.K., and Iwasaki A. Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol. 19 (2007) 48-55
23. Li G., Kim Y.J., and Broxmeyer H.E. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential. J. Immunol. 174 (2005) 4706-4717
24. Liang S., Alard P., Zhao Y., Parnell S., Clark S.L., and Kosiewicz M.M. Conversion of CD4+CD25- cells into CD4+CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201 (2005) 127-137
25. Menetrier-Caux C., Montmain G., Dieu M.C., Bain C., Favrot M.C., Caux C., and Blay J.Y. Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin-6 and macrophage colony stimulating factor. Blood 92 (1998) 4778-4791
26. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., Erb K., Schuler G., and Lutz M.B. Repetitive injections of dendritic cells matured with tumor necrosis factor induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195 (2002) 15-21
27. Mitrasinovic O.M., Perez G.V., Zhao F., Lee Y.L., Poon C., and Murphy Jr. G.M. Overexpression of macrophage colony stimulating factor Receptor on microglial cells induces an inflammatory response. J. Biol. Chem. 276 (2001) 30142-30149
28. Nishina T., Naomoto Y., Gouchi A., Gunduz M., Shirakawa Y., Nobuhisa T., Motoki T., Kusaka S., Haisa M., Matsuoka J., Nakayama E., and Tanaka N. Macrophage colony-stimulating factor inhibits tumor necrosis factor production and prolongs skin graft survival. Transplantation 77 (2004) 456-459
29. Piccinni M.P., Scaletti C., Vultaggio A., Maggi E., and Romagnani S. Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J. Reprod. Immunol. 52 (2001) 35-43
30. Raimondi G., Zanoni I., Citterio S., Ricciardi-Castagnoli P., and Granucci F. Induction of peripheral T cell tolerance by antigen-presenting B cells. I. Relevance of antigen presentation persistence. J. Immunol. 176 (2006) 4012-4020
31. Reddy J., Illes Z., Zhang X., Encinas J., Pyrdol J., Nicholson L., Sobel R.A., Wucherpfennig K.W., and Kuchroo V.K. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15434-15439
32. Rifa'i M., Kawamoto Y., Nakashima I., and Suzuki H. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J. Exp. Med. 200 (2004) 1123-1134
33. Saalmüller A. New understanding of immunological mechanisms. Vet. Microbiol. 117 (2006) 32-38
34. Shevach E.M., DiPaolo R.A., Andersson J., Zhao D.M., Stephens G.L., and Thornton A.M. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol. Rev. 212 (2006) 60-73
35. Smith W., Feldmann M., and Londei M. Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. Eur. J. Immunol. 28 (1998) 2498-2507
36. Steinbrink K., Wolfl M., Jonuleit H., Knop J., and Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159 (1997) 4772-4780
37. Tuve S., Chen B.M., Liu Y., Cheng T.L., Touré P., Sow P.S., Feng Q., Kiviat N., Strauss R., Ni S., Li Z.Y., Roffler S.R., and Lieber A. Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses. Cancer Res. 67 (2007) 5929-5939
38. Unanue E.R. Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 2 (1984) 395-428
39. Wilbanks G.A., Mammolenti M., and Streilein J.W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur. J. Immunol. 22 (1992) 165-173
40. Xiao B.G., Huang Y.M., Yang J.S., Xu L.Y., and Link H. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats. Clin. Exp. Immunol. 125 (2001) 300-309
41. Yanai N., Yamada M., Motoyoshi K., Yokota H., Yoshida K., Kawashima M., Nishida T., Miura M., and Saito M. Effect of human macrophage colony-stimulating factor on granulopoiesis and survival in bone-marrow-transplanted mice. Jpn. J. Cancer Res. 81 (1990) 355-362
42. Zhang G.X., Yu S., Gran B., Li J., Siglienti I., Chen X., Calida D., Ventura E., Kamoun M., and Rostami A. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. J. Immunol. 171 (2003) 4485-4492
43. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., and Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16 (2004) 249-256
44. Zheng Y., and Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8 (2007) 457-462